Skip to main content
Caplight Logo









Senseera

Senseera

Private
JerusalemHealthcare & Life Scienceshttps://senseerahealth.com/

Last Round

Seed

Jan 7, 2025

Total Funding Raised

$7.1M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Senseera is a biotechnology company that develops liquid biopsy blood tests using chromatin epigenomics to provide insights for disease detection and monitoring.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

liquid biopsycfChIP-seqepigenomicsprecision medicinebiomarker discoveryclinical trial monitoringdrug efficacychromatin immunoprecipitationgene expression modelingcontract research organizationCROdata as a serviceDaaSmulti-omicsai-driven diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Senseera Comparables

Compare Senseera with similar companies based on industry and business-model similarity.

Senseera comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Precede Biosciences
81%
Hepta Bio
78%
ClearNote Health
77%

Senseera Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 7, 2025

Key People

Founding team and executive leadership

Jenia Gutin

Co-Founder and CTO

Founding Team

Ronen Sadeh

Co-Founder and CEO at Senseera

Founding Team

Senseera Investors

Notable investors and investment history

Senseera investors
InvestorRounds
Lightspeed Venture PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 104% MoM, reaching 1.1K.

  • Jun 17, 2026

    Monthly visitors increased 568% MoM.

Senseera Filings

Explore SEC and related filing metadata, where available.

Senseera filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Senseera's valuation, stock price, and market status.

Is Senseera a public or private company?

Senseera is a private company.

What is the current stock price of Senseera?

Senseera is a private company with no public stock price. Caplight tracks Senseera's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Senseera worth (valuation)?

Valuation information for Senseera is not publicly available.

Can I buy Senseera stock?

Senseera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Senseera's last funding round?

Senseera's most recent funding round was Seed on January 7, 2025.

Who are the main investors in Senseera?

Key investors in Senseera include Lightspeed Venture Partners.

Will Senseera IPO soon?

No public IPO plans have been announced for Senseera.

How can I track Senseera secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Senseera's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersJerusalem
Employee Range15
Year Founded2020
Last FundingJan 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?